SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000929638-23-001859
Filing Date
2023-06-29
Accepted
2023-06-29 06:56:54
Documents
5
Group Members
SHENANDOAH ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 TENDER OFFER STATEMENT sctoc.htm SC TO-C 24286
2 JOINT PRESS RELEASE exhibit99-1.htm EX-99.1 20543
3 footer_lilly.jpg GRAPHIC 9451
4 logo_lilly.jpg GRAPHIC 11548
5 logo_sigilon.jpg GRAPHIC 6727
  Complete submission text file 0000929638-23-001859.txt   85109
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Subject) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-92195 | Film No.: 231054258
SIC: 2834 Pharmaceutical Preparations